INTRODUCTION
============

Endometrial cancer is the fourth most common cancer in women in the United Kingdom. Each year, more than 7000 cases are diagnosed,[@nuu063-B1]^,^[@nuu063-B2] Endometrial cancer has one of the highest survival rates; 75% of diagnosed women are likely to survive for at least 10 years.[@nuu063-B1] Given these data, research on the survivorship population is of considerable importance.

Endometrial cancer survivors experience decreased health-related quality of life (HRQoL), primarily due to cancer and its treatment.[@nuu063-B3] Other factors, however, like lifestyle behaviors, may also play a role. Evidence from the general cancer survivorship literature suggests that meeting nutritional and physical activity recommendations is positively associated with HRQoL.[@nuu063-B4] A recent Cochrane review indicated that exercise interventions significantly improve HRQoL in cancer survivors.[@nuu063-B5] Nevertheless, there is a high prevalence of low physical activity, poor dietary quality, and obesity among endometrial cancer survivors,[@nuu063-B6] many of whom demonstrate low physical fitness levels[@nuu063-B7] and have persistent and long-term treatment effects like fatigue[@nuu063-B6] and mild bowel injury symptoms.[@nuu063-B8] These conditions and persistent treatment-related symptoms have been associated with poorer HRQoL in this population.

Despite the robust evidence regarding the effects of diet, physical activity, and obesity on endometrial cancer risk,[@nuu063-B9] data on these factors and outcomes for survivors of endometrial cancer are limited. The purpose of this review is to explore the associations of obesity (body mass index \[BMI\], body composition), diet (food groups, dietary patterns), and physical activity with HRQoL in survivors of endometrial cancer.

LITERATURE SEARCH METHODS
=========================

Eligibility criteria
--------------------

The population of interest included survivors of endometrioid carcinoma stages I--IV.[@nuu063-B10]^,^[@nuu063-B11] Due to differences in morphology and prognosis, clear cell or papillary serous carcinomas as well as sarcomas were excluded.[@nuu063-B12] Survivors were defined as those surviving after the end of primary or adjuvant therapy treatment with or without recurrent disease. Studies investigating the associations of obesity, diet, and physical activity with HRQoL in survivors of endometrial cancer were eligible (see [Appendix S1](http://nutritionreviews.oxfordjournals.org/lookup/suppl/doi:10.1093/nutrit/nuu063/-/DC1) available in the Supporting Information for this article online). Inclusion was limited to studies that reported a measure of the effect or association between the variables and HRQoL.

### Assessment of HRQoL.

HRQoL was conceptually defined as subjective assessments of physical well-being and symptoms (e.g., functional activities, fatigue, pain), social well-being (e.g., family distress, work), psychological well-being (e.g., anxiety, depression), and spiritual well-being (e.g., uncertainty, hope).[@nuu063-B13] A conceptual definition was used because there is no commonly accepted definition of HRQoL, though it is broadly accepted to be a multidimensional, self-rated measure of well-being.

The questionnaires most commonly used to assess HRQoL are the European Organization for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30),[@nuu063-B14] the Functional Assessment for Cancer Therapy--General (FACT-G),[@nuu063-B15] and the Short-Form 36-Item Health Survey (SF-36).[@nuu063-B16] These are standardized tools, and a comparison of their characteristics is shown in [Table 1](#nuu063-T1){ref-type="table"}. The physical, emotional, and functional subscales of the EORTC QLQ-C30 and the FACT-G are sufficiently similar to allow direct comparisons.[@nuu063-B17] The same applies to the physical functioning, emotional functioning/mental health, and pain subscales of the EORTC QLQ-C30 and SF-36.[@nuu063-B18] The correlations between the FACT-G physical well-being score and the SF-36 physical composite score as well as between the FACT-G emotional well-being score and the SF-36 mental composite score are also strong.[@nuu063-B19] Thus, the operational definition of HRQoL included overall HRQoL, 4 well-being domains (physical, functional, emotional, and social), and 2 symptoms (fatigue and pain). Table 1Characteristics of the three questionnaires commonly used to assess health-related quality of lifeCharacteristicFACT-G (27 items)EORTC QLQ-C30 (30 items)SF-36 (36 items)Overall structure4 scales of well-being5 scales of functioning and 9 scales of symptoms7 scales of functioning and 1 scale of symptoms, clustered in 2 composite scoresScalingWell-being scalesFunctional scalesPhysical health Physical well-being (7 items) Physical functioning (5 items) Physical functioning (10 items) Functional well-being (7 items) Role functioning (2 items) Role physical (4 items) Emotional well-being (6 items) Emotional functioning (4 items) Bodily pain (2 items) Social/family well-being (7 items) Social functioning (2 items) General health (5 items)Symptoms Cognitive functioning (items)Mental health Fatigue (13 items)[^a^](#nuu063-TF2){ref-type="table-fn"}Symptom scales/items Role emotional (3 items) Anemia (7 items)[^a^](#nuu063-TF2){ref-type="table-fn"} Fatigue (3 items) Social functioning (2 items) Pain (2 items) Mental health (5 items) Nausea and vomiting (2 items) Vitality (4 items) Dyspnea, insomnia, constipation,  diarrhea, appetite loss, financial  difficulties (1 each)Overall score (27 items)Global health status/QoL (2 items)Item deliveryStatementsQuestionsBoth questions and statementsResponse optionsLikert scales with 5 optionsLikert scales with 4 or 7 optionsLikert scales with 3, 5, or 6 optionsYes/no questionsRecall periodPast 7 daysPast weekPast 4 weeks[^1][^2]

Identification of studies
-------------------------

Embase, MEDLINE via PubMed, Cochrane, and PsycINFO databases were searched from database inception until January 2014, with no language restrictions. Reference lists from included papers were scanned visually. The following websites were also included in the search: World Health Organization International Clinical Trials Registry Platform ([www.who.int/ictrp/en](http://www.who.int/ictrp/en)), Current Controlled Trials ([www.controlled-trials.com](http://www.controlled-trials.com)), and ClinicalTrials.gov ([www.clinicaltrials.gov](http://www.clinicaltrials.gov)). To identify unpublished literature, relevant conference proceedings were searched manually, and experts were contacted for preliminary results of ongoing studies. An experienced academic librarian contributed to the search protocol (see [Appendix S2](http://nutritionreviews.oxfordjournals.org/lookup/suppl/doi:10.1093/nutrit/nuu063/-/DC1) in the Supporting Information online), which included relevant terms for the following domains: diet, energy balance, body composition, physical activity, fatigue, pain, HRQoL, and physical, psychological, social, and spiritual well-being.

Study selection
---------------

One researcher (D.A.K.) reviewed the titles and abstracts and, subsequently, the full texts of those references that seemed to satisfy inclusion criteria. In the interest of time, authors were not contacted. The team discussed potential ambiguities before making a final decision on study inclusion. Duplicate reports of any study were regarded as a single study. Duplication was identified through sample size, authorship, and methodology, and the most appropriate data sets were selected. If data from the primary papers could not be extracted, a secondary analysis of more than 1 study was included in the analysis.

Data extraction
---------------

Data were extracted using EndNote X7 and Microsoft Excel 2011. The guidelines from the Centre for Reviews and Dissemination[@nuu063-B20] were followed to generate the data extraction forms ([Appendix S3](http://nutritionreviews.oxfordjournals.org/lookup/suppl/doi:10.1093/nutrit/nuu063/-/DC1) available in the Supporting Information online).

Quality assessment
------------------

Methodological quality was assessed through the Scottish Intercollegiate Guidelines Network (SIGN) checklists.[@nuu063-B21] Quality of reporting was based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for observational studies[@nuu063-B22] and the Consolidated Standards of Reporting Trials (CONSORT) statement for clinical trials.[@nuu063-B23] Data on quality assessment of the cohorts and trials are available in [Appendix S4](http://nutritionreviews.oxfordjournals.org/lookup/suppl/doi:10.1093/nutrit/nuu063/-/DC1) in the Supporting Information online.

### Data synthesis.

As only 2 randomized controlled trials (RCTs) were identified, the data were synthesized narratively.[@nuu063-B24] Studies were clustered primarily by outcome measures. To allow comparisons between different measurement tools and sample sizes, standardized mean differences (effect sizes) were produced by calculating Cohen's *d* \[*d* = (mean~1 ~--~ ~mean~2~)/SD~pooled\]~ between nonobese (i.e., normal-weight and overweight) and obese (all categories) subjects and between those meeting guidelines (as defined in the papers) and those who did not. In order for data from Blanchard et al. (2010)[@nuu063-B25] to be included in the analysis, the obese and nonobese groups in the study were assumed to be of equal size. Fatigue and pain scales were corrected for directional differences, so that all scales have the same direction. Standardized mean differences were defined as small if *d* = 0.2, medium if *d* = 0.5, and large if *d* = 0.8.[@nuu063-B26]

RESULTS
=======

In total, 4382 records were identified. Of those, 12 reports of 8 studies were included in the final analysis. The flowchart ([Figure 1](#nuu063-F1){ref-type="fig"}) shows the study selection process and the reasons for exclusion. Four of the 8 studies were cross-sectional, 1 was retrospective, 1 was prospective, and 2 were RCTs. The evaluation tools most widely used were the EORTC QLQ-C30, the SF-36, and the FACT-G. Figure 1Flowchart of the literature search and selection process

[Table 2](#nuu063-T2){ref-type="table"}[@nuu063-B4]^,^[@nuu063-B27] shows the 4 studies that assessed overall HRQoL. Three were cross-sectional and 1 was retrospective. Two used the SF-36, 1 the EORTC, and 1 the FACT instrument, but all showed similar patterns of improved HRQoL with lower BMI and healthier lifestyle behaviors. Specifically, 3 studies assessed the impact of BMI on HRQoL. Two of them found small to medium differences of 0.21 (0.04--0.37) and 0.29 (0.01--0.59) on HRQoL between the nonobese and obese groups,[@nuu063-B28]^,^[@nuu063-B29] and 1 found large differences (0.75 \[0.54--0.96\]).[@nuu063-B27] The last study showed an improved general HRQoL with lower BMI and increased physical activity after adjusting for major confounders. Furthermore, there was a large size difference of 0.78 (0.30--1.26) in HRQoL in survivors who met the physical activity guidelines, consumed 5 servings of fruits and vegetables per day, and abstained from smoking.[@nuu063-B4] Table 2Effects of exposure variables on health-related quality of life (HRQoL)ReferenceDesignNo. of subjectsBody composition measureDietary measurePhysical activity measureHRQoL measureMean difference/coefficient (95% CI)Covariates includedSmits et al. (2013)[@nuu063-B29]Retrospective follow-up: 2.5 y158BMI extracted from medical recordsN/AN/AEORTC QLQ-C30*d* nonobese vs obese: 0.29 (0.01--0.59)Patient characteristicsCourneya et al. (2005)[@nuu063-B27]Cross-sectional386Self-reported weight & heightN/AModified Leisure score index from GLTEQTotal FACT-An*d* nonobese vs obese: 0.75 (0.54--0.96)Age, marital status, education, income, disability, time since diagnosis disease stage, tumor grade, adjuvant therapyBMI on QoL, β = −0.17, *P* \< 0.001*d* PA vs no PA: 0.48 (0.38--0.58)Exercise on QoL, β = 0.21, *P* \< 0.001Oldenburg et al. (2013)[@nuu063-B28]Cross-sectional666Self-reported weight & heightN/AN/ASF-36General health *d* nonobese vs obese: 0.21 (0.04--0.37)Age, education, marital status, treatment, time since diagnosis, no. of comorbiditiesBMI on general health, β = 0.50, *P* \> 0.05Blanchard et al. (2008)[@nuu063-B4]Cross-sectional729Self-reported BMISelf-reported assessed by question: How many days per week do you eat at least 5 servings of FV a day?GLTEQL: met/did not meet ACS PA recommendationSF-36Meeting PA recommendation vs not: *d* = 0.3Race, stage, education, marital status, total no. of comorbiditiesEating 5-a-day vs not: *d* = 0.1PA and 5-a-day and no-smoking vs not meeting the guidelines: *d*=0.78 (0.30--1.26)[^3]

Effect sizes regarding HRQoL domains and symptoms are shown in [Table 3](#nuu063-T3){ref-type="table"}.[@nuu063-B4]^,^[@nuu063-B6]^,^[@nuu063-B25]^,^[@nuu063-B27] Better scores for physical well-being were universally demonstrated in the nonobese groups, but with wide variability that ranged from small to large effect sizes. Two of the 3 studies found significantly better physical well-being scores[@nuu063-B27]^,^[@nuu063-B30] in those meeting the physical activity guidelines, with the magnitude of difference being medium to large. Marginally better scores or nonsignificant trends toward them were demonstrated for functional well-being in nonobese and physically active survivors. Table 3Effect of exposure variables on health-related quality of life (HRQoL) domains and symptomsReferenceHRQoL measureStandardized mean difference (95%CI); *d* = (mean~1~--mean~2~)/SD~pooled~BMI (nonobese vs obese)Physical activity (met vs did not meet guidelines)Physical well-being    Courneya et al. (2005)[@nuu063-B27]FACT-G PWB0.19 (0.01--0.40)0.43 (0.21--0.65)    von Gruenigen et al. (2011)[@nuu063-B6] [^a^](#nuu063-TF8){ref-type="table-fn"}FACT-G PWB--0.16 (−0.43 to 0.75)[^b^](#nuu063-TF9){ref-type="table-fn"}    Fader et al. (2011)[@nuu063-B31] [^c^](#nuu063-TF10){ref-type="table-fn"}FACT G PWB0.81 (0.40--1.23)--    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 PF0.45 (0.15--0.74)--    Oldenburg et al. (2013)[@nuu063-B28]SF-36 PF0.76 (0.59--0.93)--    Basen-Engquist et al. (2009)[@nuu063-B30]SF-36 PF0.66 (0.28--1.04)0.86 (0.40--1.32)    Blanchard et al. (2010)[@nuu063-B25]SF-36 PHc0.44 (0.20--0.69)--Functional well-being    Courneya et al. (2005)[@nuu063-B27]FACT-G FWB0.05 (−0.16 to 0.26)0.26 (0.04--0.48)    von Gruenigen et al. (2011)[@nuu063-B6] [^a^](#nuu063-TF8){ref-type="table-fn"}FACT-G FWB--0.35 (−0.25 to 0.95)[^b^](#nuu063-TF9){ref-type="table-fn"}    Fader et al. (2011)[@nuu063-B31] [^c^](#nuu063-TF10){ref-type="table-fn"}FACT-G FWB0.19 (−0.22 to 0.60)--    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 RF0.31 (0.01--0.60)--Emotional well-being/mental health    Courneya et al. (2005)[@nuu063-B27]FACT-G EWB0.06 (−0.14 to 0.27)0.14 (−0.07 to 0.36)    von Gruenigen et al. (2011)[@nuu063-B6] [^a^](#nuu063-TF8){ref-type="table-fn"}FACT-G EWB--0.45 (−0.15 to 1.05)[^b^](#nuu063-TF9){ref-type="table-fn"}    Fader et al. (2011)[@nuu063-B31] [^c^](#nuu063-TF10){ref-type="table-fn"}FACT-G EWB0.12 (−0.28 to 0.53)--    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 EF0.25 (0.09--0.42)--    Oldenburg et al. (2013)[@nuu063-B28]SF-36 MHs0.12 (−0.04 to 0.29)--    Blanchard et al. (2010)[@nuu063-B25]SF-36 MHc0.16 (−0.09 to 0.40)--Social well-being    Courneya et al. (2005)[@nuu063-B27]FACT-G SWB0.20 (−0.01 to 0.41)0.33 (0.23--0.33)    Fader et al. (2011)[@nuu063-B31] [^c^](#nuu063-TF10){ref-type="table-fn"}FACT-G SWB0.30 (0.14--0.46)--    Oldenburg et al. (2013)[@nuu063-B28]SF-36 SF0.12 (0.05--0.20)--    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 SF0.25 (−0.05 to 0.54)--Fatigue    Courneya et al. (2005)[@nuu063-B27]FACIT-F−0.42 (−0.62 to −0.21)−0.40 (−0.61 to −0.18)    von Gruenigen et al. (2011)[@nuu063-B6] [^a^](#nuu063-TF8){ref-type="table-fn"}FACIT-F--−0.54 (−1.14 to 0.06)[^b^](#nuu063-TF9){ref-type="table-fn"}    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 F−0.28 (−0.58 to 0.01)--    Oldenburg et al. (2013)[@nuu063-B28]FAS−0.34 (−0.50 to −0.17)--    Basen-Engquist et al. (2009)[@nuu063-B30]BFI0.04 (−0.33 to 0.41)−0.44 (−0.89 to 0.01)Pain    Basen-Engquist et al. (2009)[@nuu063-B30]BPI−0.11 (−0.48 to 0.26)−0.52 (−0.97 to −0.07)    Smits et al. (2013)[@nuu063-B29]EORTC QLQ-C30 P−0.30 (−0.59 to −0.01)--    Oldenburg et al. (2013)[@nuu063-B28]SF-36 BP−0.47 (−0.64 to 0.31)--[^4][^5][^6][^7]

Emotional well-being was slightly better in 1 of 5 studies in nonobese subjects[@nuu063-B29] and was nonsignificantly better in the rest. There was a trend toward better emotional well-being in those who met the physical activity goals (0.14 \[−0.07 to 0.36\])[@nuu063-B27] and in those who met 2 of the 3 health behavior recommendations compared with those who did not (0.45 \[−0.15 to 1.05\]).[@nuu063-B6] Small significant differences in social well-being between BMI categories were reported in 2 of 4 studies.

Furthermore, findings for nonobese and physically active survivors showed either a nonsignificant trend or significantly lower fatigue scores of a medium effect size (0.28--0.54), apart from 1 study that reported slightly increased fatigue in nonobese subjects (0.04 \[−0.33 to 0.41\]).[@nuu063-B30] Finally, pain was lower in the nonobese groups, with the difference between the nonobese and the obese groups ranging from −0.11 to −0.47, and scores showing a medium size difference (−0.52 \[−0.97 to −0.07\]) in favor of the physically active group in 1 study.[@nuu063-B30]

Data from the 2 clinical trials on lifestyle interventions for weight loss ([Table 4](#nuu063-T4){ref-type="table"}[@nuu063-B35]^--^[@nuu063-B35]) partly support the prospective, retrospective, and cross-sectional data on HRQoL domains and symptoms. Only 1 of these trials showed a significant difference in fatigue after 3 months (*P* = 0.008) and in physical functioning after 6 months (*P* = 0.048).[@nuu063-B32] However, neither of these trials was statistically powered to detect differences in quality of life, and both may suffer from selection bias, as many participants were following relatively healthy lifestyles. Their methodological quality was scored as acceptable[@nuu063-B32] or low.[@nuu063-B34] Table 4Health-related quality of life after lifestyle interventionsReferenceStudy characteristicsTotal no. of subjectsBody composition measureDietary measurePhysical activity measureHRQoL measureMean difference between groups at 12 mo/coefficient (95% CI)Covariates includedvon Gruenigen et al. (2008)[@nuu063-B34]; von Gruenigen et al. (2009)[@nuu063-B35]RCT45 ITTBMI measured3-day dietary records performed on 1 weekend and 2 weekdays at 3, 6, & 12 mo4-item leisure score index from Godin Leisure-Time Exercise Questionnaire, (classified as mild,moderate, or strenuous)FACIT-FEffect size at 12 mo (LI--UC)Baseline measurementStage I/II endometrial cancerResponse rate: 40%Effect size at 12 mo (LI--UC): BMI,Effect size at 12 mo (LI--UC): total intake, −90 kcal; vitamin CEffect size at 12 mo (LI--UC): LSI, 15.8\*\*; pedometer, NRHRQoL−0.14 (−0.61 to 0.33)LI for 6 mo vs UCAttrition rate: 16%−0.5 kg/m^2^; weight, −4.9 kg[\*](#nuu063-TF5){ref-type="table-fn"}intake, 15.6 mg; folate intake, 101.4 μg)Physical WB−0.10 (−0.57 to 0.38)FU: 12 moCompletion rate: 80%Functional WB−0.13 (−0.61 to 0.35)Type I EC: 100%Adherence rate: 73%Emotional WB−0.29 (−0.77 to 0.18)Social WB0.10 (−0.38 to 0.57)Fatigue−0.15 (−0.62 to 0.32)SF-36NRMcCarroll et al. (2013)[@nuu063-B32]; von Gruenigen et al. (2012)[@nuu063-B33]RCT75 ITTBMI measuredTwo 24-h recalls: 1 classified as FV servings/d and 1 classified as kcal/dFour-item LSI from Godin Leisure-Time Exercise Questionnaire, along with duration questions 7-day pedometer step test at baseline and 6 moFACT-G (assessed at baseline and 3, 6, and 12 mo)Fatigue at 3 mo significantly different between groups, *P* = 0.008Age, time since diagnosis, stage, adjuvant treatment, comorbidities, and baseline measurementStage I/II endometrial cancerResponse rate: 19%Body composition using DXA (NR)Physical function at 6 mo significantly different between groups, *P* = 0.048LI for 6 mo vs UCAttrition rate: 21%Biomarkers (NR)Total FACT-G score was improved in the LI group from baseline to 3 mo (*P* \< 0.05) and 6 mo (*P* \< 0.001)FU: 12 moCompletion rate: 78%Effect size at 12 mo (LI--UC): BMI, −1.8 kg/m^2;^ weight, −4.6 kg\*\*\*; waist circum., −1.6 cm[\*](#nuu063-TF5){ref-type="table-fn"}Effect size at 12 mo (LI--UC): total intake, −187 kcal\*\*\*; FV, 0.9 servings/d\*\*\*Effect size at 12 mo (LI--UC): LSI, 7.8 points\*\*\*; minutes of PA, 89 min/wk\*\*\*; pedometer, not measured at 12 moType I EC: 100%Adherence rate: 84%[^8][^9]

DISCUSSION
==========

Both obesity and the failure to meet guidelines for healthy lifestyle behaviors were negatively associated with HRQoL. Associations were stronger for the HRQoL domain of physical well-being and a subscale measure of fatigue. Overall, the effect sizes, although limited and for which wide standard deviations were found, are of a magnitude similar to that in the general population[@nuu063-B36] and in survivors of different types of cancer, such as breast, prostate, and colorectal.[@nuu063-B4]^,^[@nuu063-B37]^,^[@nuu063-B38] This further strengthens the hypothesis that maintaining a healthy lifestyle by being physically active, meeting dietary guidelines, abstaining from smoking, and maintaining a healthy weight correlates with an improved quality of life in this group of cancer patients. However, as most of the studies reviewed were cross-sectional, causality cannot be inferred.

The current results are consistent with a meta-analysis of cancer survivors who demonstrated an improved quality of life following exercise interventions.[@nuu063-B5] Although a recent analysis showed that attaining desirable exercise levels might be unlikely in cancer survivors, behavioral interventions showed an improvement in aerobic capacity,[@nuu063-B39] a strong predictor of mortality.[@nuu063-B40] Given the low physical fitness levels of endometrial cancer survivors[@nuu063-B7] and findings that indicate only small changes are needed to provide substantial health benefits,[@nuu063-B41] facilitating the physical activity levels of this population is imperative. Furthermore, exercise seems to ameliorate cancer-related fatigue,[@nuu063-B42] although this type of fatigue may be driven more by dysfunctions of the central nervous system than by abnormal muscle metabolism (as in malnutrition-related fatigue).[@nuu063-B43] Further mechanistic studies can provide insight on this.

It would have been desirable, but was not possible, to establish dose-response relationships. However, many studies[@nuu063-B4]^,^[@nuu063-B27] indicated a tendency toward an inverse association between unhealthy lifestyle and HRQoL assessments, which seems consistent among survivors of different types of cancer.[@nuu063-B4] No clear evidence of an association between body composition and HRQoL, or of the effects of diet on HRQoL, has been described. Objective body composition and serum biomarker measurements had been pre-specified in the protocol of the SUCCEED trial.[@nuu063-B32] A future report from the trial may provide further insight into the nutritional status of endometrial cancer survivors, given that central adiposity is a stronger predictor of mortality in women than BMI.[@nuu063-B44]

Regarding weight loss, it is generally accepted that unintentional weight loss is a clear risk factor for a worse prognosis. Unfortunately, the scarcity of data does not allow firm conclusions about intentional weight loss in endometrial cancer survivors. However, valid points can be drawn from the largest trials in other cancer survivors and from the broad body of literature on obese older adults. The literature from the general obese elderly population strongly supports that HRQoL -- especially physical function -- and cardiometabolic risk factors will be improved by a lifestyle intervention that involves weight loss; moreover, the side effects of such an intervention are minor.[@nuu063-B45] The underlying mechanisms are beyond the scope of this discussion but have been previously documented.[@nuu063-B48] Evidence from cancer survivors supports the benefits for physical function following a 1-year home-based weight loss, diet-and-exercise intervention.[@nuu063-B49] Importantly, adherence to the lifestyle intervention strongly correlated with HRQoL outcomes in cancer survivors,[@nuu063-B50] and ceasing the intervention reduced the beneficial effects of lifestyle interventions.[@nuu063-B49]^,^[@nuu063-B51] Survivors of early-stage endometrial cancer do not experience a high burden of symptoms[@nuu063-B29] and are most likely to die from cardiovascular disease long after their cancer diagnosis.[@nuu063-B52] Although the results of large-scale weight-loss interventions in breast cancer survivors are still awaited,[@nuu063-B53] these findings indicate that intentional weight loss might be beneficial in survivors of early-stage endometrial cancer, particularly if it incorporates physical activity that includes resistance training.

As far as can be determined, this is the first report of an association between HRQoL and obesity, diet, and physical activity in endometrial cancer survivors. The review was conducted following the PRISMA guidelines,[@nuu063-B54] but given the broad scope of the review, intervention and comparison criteria were not prespecified. A comprehensive search strategy was used to identify potential studies. Although the results are based only on published data, future studies should adhere to guidelines for quality of reporting. No study reported objective measures of physical activity. Most studies used self-reported, validated questionnaires, which are prone to recall and social desirability bias.

Despite the discrepancy in the scales of the HRQoL instruments -- the FACT-G measures well-being, whereas the EORTC QLQ-C30 and SF-36 measure functional assessments -- the similarity of most of the scales is sufficient to allow direct comparisons to be made, as indicated in the discussion of assessment of HRQoL below. The nonsignificant results in the social well-being category are not very informative, primarily because of the important differences among the instruments used to measure this scale.[@nuu063-B55] To eliminate the effects of each instrument, standardized mean differences were calculated where possible. Importantly, the observed differences are based on subjective assessments and, therefore, rely on the individual's perceptions of the level of each scale they experience, which may vary among individuals. While Cohen's effect sizes determine statistically significant differences, they seem to correlate well with clinical significance.[@nuu063-B56] Thus, the medium size differences in overall HRQoL, physical well-being, and fatigue may be cautiously interpreted as clinically important differences that can guide implementation of interventions and policy decisions. Even the small size differences may be important because of the large population of endometrial cancer survivors and the high prevalence of obesity and unhealthy lifestyle among them.

Findings may not be generalizable because of the lack of sociodemographic data reporting. Given the high level of education and lack of ethnic diversity among participants in studies that collected such data, the results may not apply to the broader population of endometrial cancer survivors, who are often of low socioeconomic level.[@nuu063-B1]

Implications for practice and research
--------------------------------------

Future research should address the longitudinal effect of weight control, exercise, and diet after a diagnosis of endometrial cancer and should examine the potential effects on HRQoL. In light of funding constraints, HRQoL, an indicator of survival,[@nuu063-B57] could be a valuable alternative method of evaluating prognosis, but this remains to be elucidated in endometrial cancer survivors affected mostly by early-stage disease, since evidence from breast cancer survivors suggests that HRQoL is predictive of survival in advanced-stage, but not early-stage, disease.[@nuu063-B57]

Interventions targeting more representative samples of cancer survivors can increase the generalizability of the findings. Behavior change can be challenging, however, due to socioeconomic and environmental barriers,[@nuu063-B58] which include restricted access to recreational facilities and the increased cost of healthier diets. Further challenges include cancer-related effects like fatigue, limited social support, lack of motivation, and uncertainty about the effects of diet.[@nuu063-B58] Self-monitoring, social support, practice, and rewards are effective in improving physical activity when incorporated into lifestyle interventions.[@nuu063-B61] Contrarily, the relevant effectiveness of techniques to achieve dietary change is more obscure, given the inaccuracy of dietary reporting in most trials.[@nuu063-B62] Self-efficacy about weight management improved following lifestyle interventions in survivors of early-stage endometrial[@nuu063-B32] and other cancers.[@nuu063-B63]

While data are limited in this population, it is reasonable to speculate that sarcopenia, and even cachexia, could be prevalent.[@nuu063-B64] These conditions add significantly to the mortality burden of obesity.[@nuu063-B65] Accordingly, further research should extend to anthropometric indices other than BMI, like waist-to-height ratio, handgrip strength, and body composition analysis, and should also focus on the effects of resistance training and a plant-based, protein-sufficient diet. Notably, interventions should be supported by appropriate policy actions[@nuu063-B66] in order to be efficacious.

CONCLUSION
==========

The data, while predominantly cross-sectional, indicate that overall HRQoL and physical well-being are positively correlated with adherence to lifestyle recommendations, while fatigue is negatively associated with adherence. Future RCTs should evaluate health behavior change interventions (determining the safety, frequency, duration, intensity, and delivery mode) in endometrial cancer survivors.
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[^1]: *Abbreviations*: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Core Questionnaire; FACT-G, Functional Assessment for Cancer Therapy--General; QoL, quality of life; SF-36, Short-Form 36-Item Health Survey.

[^2]: ^a^Additional subscales in the FACT-G. Not counted in the overall score of FACT-G but counted in the overall score of FACIT-F (Functional Assessment for Chronic Illness Therapy-Fatigue) and/or FACT-An (anemia).

[^3]: *Abbreviations*: ACS PA, American Cancer Society physical activity recommendations; BMI, body mass index; *d*, standardized mean difference; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Core Questionnaire; FACT-An, Functional Assessment for Cancer Therapy--Anemia; FACT-G, Functional Assessment for Cancer Therapy--General; FV, fruit and vegetables; GLTEQ, Godin Leisure-Time Exercise Questionnaire; PA, physical activity; SF-36, Short-Form 36-Item Health Survey.

[^4]: *Abbreviations*: BFI, Brief Fatigue Inventory; BP, bodily pain; BPI, Brief Pain Inventory; EF, emotional functioning; EWB, emotional well-being; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Core Questionnaire; FACIT-F, Functional Assessment of Chronic Illness Therapy--Fatigue; FACIT-G, Functional Assessment of Chronic Illness Therapy--General; FAS, Fatigue Assessment Survey; FWB, functional well-being; MHc, mental health composite score; MHs, mental health score; P, pain; PF, physical function, PHc, physical composite score; PWB, physical well-being; RF, role-functional; SF, social functioning; SF-36, Short-Form 36-Item Health Survey; SWB, social well-being.

[^5]: ^a^Secondary analysis of McCarroll et al.,[@nuu063-B32] von Gruenigen et al.[@nuu063-B34]

[^6]: ^b^Meeting either 5-a-day and no smoking or 150 min/wk and no smoking.

[^7]: ^c^Secondary analysis of McCarroll et al.[@nuu063-B32] von Gruenigen et al.[@nuu063-B34] von Gruenigen et al.[@nuu063-B67]

[^8]: *Abbreviations*: BMI, body mass index; circum., circumference; DXA, dual-energy X-ray absorptiometry; EC, endometrial cancer; FACIT-F, Functional Assessment of Chronic Illness Therapy--Fatigue; FACT-G, Functional Assessment for Cancer Therapy--General; FV, fruits and vegetables; FU, follow-up; ITT, intention-to-treat analysis; LI, lifestyle intervention; LSI, Leisure Score Index; NR, not reported; RCT, randomized controlled trial; Vit C, vitamin C; UC, usual care; WB, well-being.

[^9]: \**P* \< 0.05, significant compared with baseline; \*\**P* \< 0.05, significant between groups; \*\*\**P* \< 0.001, between groups.
